Karsten Gavénis

Challenges for academic investigator-initiated pediatric trials for rare diseases.

O. Gross, R. Hilgers, Raees Ahmed, 2014, Clinical Therapeutics.

Introduction to DIN-specification 91315 based on the characterization of the plasma jet kINPen® MED

Thomas von Woedtke, Regina Tiede, Miriam Stella Mann, 2016 .

Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients

Tim Friede, Raees Ahmed, Oliver Gross, 2012, ISRN pediatrics.